Nomenclature | Technique | Cell type/source | Main studied aspect(s) | Ref. |
---|---|---|---|---|
Spheroid | • 100 mm2 non-adherent plastic dish • ECM gel (laminin, collagen type IV, heparin sulfate proteoglycan, entactin) | MIN6 | Spheroids as models to control unlimited growth after transplantation | [235] |
Spheroid | PDMS-based concave molds coated with bovine serum albumin | Dissociated rat islet and hepatocyte | Relationship between islets and hepatocytes for cell-based liver or T1D therapy | [236] |
Spheroid | Hanging drop | Dissociated rat islet | Assembly of nonviral PEI–mediated IL-10 cytokine gene-delivered cells into spheroids | [237] |
Spheroid | 3D clinostat (microgravity) | MIN6 | Optimization of spheroid properties for transplantation potential | [238] |
Pseudoislet Spheroid | 96-well non-adhesive prime surface plate | α-TC1 clone 6, NIT-1 and TGP52 | Effects of seeding density and cell type ratio on cell distribution, hormone mRNA level and functionality | [239] |
Spheroid | 6-well plate with PNIPAAm-coated PDMS-based microwells | NIT-1 | Therapeutic potential in STZ-induced diabetic mouse | [240] |
Spheroid | PDMS-based microwell coated with PNIPAAm | MIN6 and MAEC MIN6 and NIH3T3 | Encouragement of insulin secretion induction with companion cells | [241] |
Spheroid | 100-mm tissue culture dish | INS-1E expressing insulin-GLase | Example case to analyze protein secretion via video-rate bioluminescence imaging | [242] |
Spheroid | Layer-by-layer coating with fibronectin and gelatin followed by low cell attachment 96-well U-bottom plate | MIN6 | Cell coating for structural stability and functionality of spheroids in T1D treatment | [243] |
Spheroid | Membrane-bottomed PDMS concave microwell array | Dissociated rat islet | Development of a novel system to overcome oxygen supply limitation for functional and viable spheroid formation | [244] |
Spheroid | Microfluidic chip containing hemispheric cell culture chambers and with methyl cellulose and collagen type I containing medium feed | Human pancreatic 1.1B4 | Development of a platform with perfusion flow network that enables beta-cell spheroid assembly and measurement of beta-cell function under dynamic conditions | [245] |
Spheroid | Ultra-low attachment 100Â mm dish | MIN6-K20 | Model along with monolayer culture in the study of incretin responsiveness state of beta-cells | [246] |
Spheroid | Geometry-controlled hanging drop | βTC6 | Effects of droplet spreading on the spheroid formation and function | [247] |
Spheroid | Microfluidic chip containing PDMS-based concave microwells | Dissociated rat islet | Comparison of static culture with dynamic culture, drug testing (tolbutamide, GLP-1, rapamycin) | [115] |
Spheroid | PDMS microwell coated with PNIPAAm or collagen I | MIN6 and NIH3T3 | Alteration of cell localization by control of migration | [248] |
Spheroid | PDMS-chip and PMMA-chip | MIN6, MIN6-m9 | Study of the role of oxygen supply and antioxidant mediated minimization of reactive oxygen species during bioartificial pancreas preparation | [249] |
Spheroid | Hanging drop | MIN6 and rat bone marrow MSC | Development of heterospheroid model for functional and survival boost combined with PEG hydrogel as immunoisolation barrier | [250] |
Spheroid | Concave microwell coated with bovine serum albumin | Human liver cells transdifferentiated into insulin producing cell | Spheroid size control, improvement of actin–myosin-associated cytoskeleton changes mediated differentiation and function in vitro and STZ-induced diabetic mouse | [251] |
Spheroid | • 35 mm non-adherent petri dish • Hanging drop • Agarose 3D microwell technique • Spherical plate 5D | Dissociated rat islet | Comparison of different spheroid assembly techniques for obtaining optimum islet mimics | [252] |
Spheroid | Honeycomb polygons of PDMS | hiPSC | Cellular and functional characterization, effects of dimension, potential to establish pancreas-on-chips | [253] |
Spheroid | PDMS honeycomb sheet coated with pluronic acid | hiPSC | Transcriptomics and metabolomics profile comparison of spheroids in culture of 3D static vs. microfluidic chip | [254] |
Spheroid | Stirred-tank bioreactor | INS-1 | Effects of technique and stirrer type in the assembly, viability, functionality and yield | [255] |
Spheroid | Ultra-low binding round-bottom plate as part of differentiation process MBP-FGF2 immobilized surface as part of differentiation process | Human omentum-derived stem cell | In vitro differentiation in the spheroid formation platform, characterization, and analysis of therapeutic potential in STZ-induced diabetic mouse | [256] |
Spheroid Organoid | Amikagel containing 96-well plate during aggregation following final differentiation | Human embryonic stem cell derived pancreatic progenitor cell and HUVEC | Development and validation of a hydrogel-based system for progenitor cell differentiation towards pancreatic lineage and organoid assembly | [257] |
Spheroid Organoid | Agarose-patterned microwell | Dissociated islet and human amniotic epithelial cell | Enhancement of engraftment, viability, and graft function in STZ-induced diabetic mouse | [258] |
Organoid | Microfluidic chip with microwell configurations as part of differentiation process | hiPSC lines | iPSCs as a source of insulin-producing beta-cells for diverse uses | [259] |
Organoid | Agarose-coated 96-well plate | Dissociated mouse islet and mouse microvascular fragment | In vitro characterization and development to address challenge of insufficient vascularization after islet transplantation | [260] |
Organoid (or pseudoislet) | Ultra-low attachment 96-well microplate | Dissociated mouse islet | Assessment of spheroid potential for genetic manipulation with adeno-associated virus serotype 8 | [261] |
SC-islet (organoid) | Ultra-low attachment cell culture plate on orbital shaker | Human H1 | Model beta-cell system for the development of the reverse phase liquid chromatography-tandem mass spectrometry for insulin detection | [262] |
Pseudoislet | Tissue culture flask coated with gelatin | MIN6 | Potential of E-cadherin on the regulation of pseudoislet growth | [263] |
Pseudoislet | 90Â mm bacterial (uncoated) petri dish | MIN6 | Development of an immunoisolation barrier for cell-based therapy in T1D | [264] |
Pseudoislet | Uncoated 90Â mm petri dishes | MIN6 and mouse MSC | Testing layer-by-layer nanoencapsulation system on the spheroids as models for immunoisolation | [265] |
Pseudoislet | 6-well tissue culture plate | βTC3 and MS1 | Effect of dimension and endothelial cells on function, ECM synthesis and viability | [266] |
Pseudoislet | Ultra-low attachment, 6-well, flat-bottomed plate | Human 1.1B4 | Evaluation of pseudoislets as alternatives to natural islets for transplantation to STZ-induced diabetic mouse | [267] |
Pseudoislet | Agarose gel-based microwell | Dissociated rat islet | Characterization to investigate usefulness of pseudoislets for transplantation into STZ-induced diabetic mouse | [268] |
Pseudoislet | 2D clinostat (microgravity) followed by culture in 6 cm petri dish | EndoC-βH3 | Description of response to hypoxia | [269] |
Pseudoislet | Hanging drop | MIN6 | Optimization of alternative beta-cell model and development of CHPOA nanogel coating for immunoprotection | [270] |
Pseudoislet | 96-well spheroid microwell plate | Dissociated human islet | Characterization including cellular heterogeneity and assessment of spheroid potential for genetic manipulation with lentivirus | [271] |
Pseudoislet | Centrifugal forced aggregation in 24-well or 6-well AggreWell 400 plate | Dissociated human islet | Potential to be an alternative for native islets and superiority upon transplantation in STZ-induced diabetic mouse | [272] |
Pseudoislet | 96-well ultra-low adherent culture plate | Alpha-, beta- or delta-cells from dissociated human islet | Addressing beta-cell source limitation in the replacement therapy by reprogrammed alpha- and delta-cells | [273] |
Pseudoislet | Hanging drop | Dissociated human islet | Study of effects of glucose, adrenaline and palmitate on the regulation of insulin and glucagon secretion | [274] |
Pseudoislet | Hanging drop (GravityPLUS) | Dissociated mouse islet | Assessment of spheroid potential by adenovirus-delivered V1b receptor overexpression in vitro and STZ-induced diabetic mouse | [275] |
Pseudoislet | 6-well tissue culture plate | βTC3 and MS1 MIN6 and MS1 | Effect of dimension, endothelial cells and secretagogues on function and gene expression | [276] |
Pseudoislet | Ultra-low attachment microplate Hanging drop (GravityPLUS) | Dissociated human islet | Spheroid cell content, viability, functionality (dynamic perfusion and microfluidic system) analysis to develop representative model in GPCR signaling analysis | [277] |
Pseudoislet | 96-well plate with a non-adherent round bottom | EndoC-βH3 | Monitoring and analysis of endocrine activity in the dynamic system of a microfluidic chip that allows self-trapping of pseudoislets | [278] |
Pseudoislet | Suspension flask with stirring | INS832/3 | Characterization of insulinoma pseudoislets | [279] |
Pseudoislet | Agarose-coated microwell array | αTC1 clone 6, INS-1E and HUVEC | Analysis of cell distribution within spheroids | [280] |
Pseudoislet | PDMS microfluidic system with microtrap chambers | α-TC1 clone 6 and INS-1E | Islet-on-a-chip microfluidic 3D model for mimicking in vivo for spheroid assembly and for drug test platform for palmitic acid hydroxy stearic acid | [281] |
Pseudoislet | Low attachment microwell plate coated with pluronic acid | αTC1 clone 6 and INS-1E | Model in the discovery of the compounds effective on the reduction of oxidative stress with viability and functionality assays | [282] |
Pseudoislet | 96-well plates with V-bottom conical wells pre-treated with anti-adherence rinsing solution | Mouse and human FAC-sorted beta-cell and HUVEC | Analysis of impact of beta-cell CD63 expression in transplantation | [283] |
Pseudoislet | AggreWell 400 6-well plate followed by centrifugation and shaking, transfer to an ultralow adsorption 6-well plate | MIN6 and HUVEC | Elucidate underlying mechanism of insulin secretion augmentation in the presence of HUVECs, investigation of beta-cell markers and, analysis of therapeutic potential in STZ-induced diabetic mouse | [284] |
Pseudoislet | Agarose mold | βTC3 and RHMVEC | Spheroid characterization and endothelial sprouting in fibrin hydrogel to facilitate islet revascularization and function | [285] |
Pseudoislet | Magnetic levitation | EndoC-βH3 and HUVEC | Effects of beta-cell and endothelial cell distribution and cellular interactions on beta-cell activity | [286] |
Pseudoislet Spheroid | Hanging drop | MIN6 and hepatic/pancreatic stellate cell | Investigation of heterospheroid culture parameters on beta-cells, genetic engineering and testing stellate cells to express CCL22 to attract Tregs in vivo | [287] |
Pseudoislet Spheroid | Non-adherent culture dishes followed by rotary cell culture reactor with high aspect ratio vessel (HARV) | MIN6 and PANC-1, PaTu-8988t, FA-6 | Beta-cell and pancreatic cancer cell interaction | [288] |
Pseudoislet Spheroid Organoid | AggreWell 400 24-well plate | Dissociated rat islet, HUVEC and hAEC | In vitro characterization, xenogeneic transplantation to facilitate vascularization and engraftment | [289] |
Aggregate | Ultra-low attachment 60Â mm diameter dish | Dissociated rat islet | Comparison of natural islet and reaggregated islet response against oxidative stress and function encapsulated within alginate microcapsule and beta-cell replacement in STZ-induced diabetic mouse | [290] |
Aggregate | Culture medium dependent differentiation and aggregation | Human dental pulp stem cell | As a source for autologous stem cell therapy in diabetes | [291] |
Aggregate | Culture medium dependent differentiation and aggregation | Human adipose tissue derived stem cell | As a source for autologous stem cell therapy in STZ-induced diabetic mouse | [292] |
Aggregate | PEG microwell followed by 2Â h on orbital shaker and culture under static cultures | MIN6 | Defining optimum size with functional beta-cell mass | [293] |
Aggregate | Ultra-low attachment 24-well plate on 3D rotator | MIN6 | Mechanism of superior functional maintenance in 3D configuration | [294] |
Aggregate | Non-adherent agarose microwell | Dissociated human islets and commercial murine cell lines | Optimization of spheroid properties to minimize mass transport limitation and, validation in vivo | [295] |
Aggregate | 6-well plate on a gyratory shaker | αTC-6 and βTC-1 | Mimic heterogeneity and cellular communication | [296] |
Aggregate | Hanging drop | Mouse sertoli cell and mouse dissociated islet cell | Development of cell-based immunosuppressive therapy in beta-cell replacement in STZ-induced diabetic mouse | [297] |
Aggregate | 96-well culture plate with V-bottomed wells | INS-1 and gelatin hydrogel microspheres | Effects of microspheres on beta-cell viability and functionality | [298] |
Aggregate | Non-adherent agarose microwell chip | MIN6-B1 and HUVEC | Study of beta-cell function within membrane-based encapsulation devices and effect of endothelial cells | [299] |
Aggregate | Gelatin–PLGA porous microwell scaffolds | RIN-5F | Effects of dimensionality and microwell size on aggregation and function of beta cells | [300] |
Cluster | 12-well microplate | Dissociated rat islet cells transfected to express exendin-4 | Investigation of a novel strategy for diabetes treatment with aggregates of genetically engineered islet cells, PEG-lipid coating and anti-CD154 mAb and tacrolimus supplementation | [301] |
Cluster | Culture medium dependent differentiation and aggregation | Human adipose tissue derived stem cell | Characterization of a beta-cell source in stem cell therapy in diabetes | [302] |
Cluster | Hanging drop | Dissociated rat islet | Potential to be an alternative for native islets and superiority upon transplantation with matrigel in STZ-induced diabetic mouse | [303] |
Cluster | Culture medium dependent differentiation and aggregation in 6-well plates on an orbital shaker | Human pluripotent stem cell | As a source for stem cell therapy with dynamic response and in diabetes in vivo | [304] |
Cluster | Microwell bag | hiPSC line (1231A3 and Ff-I14s04) derived insulin secreting cell | Advancement of scalability, sterility and operability | [305] |
Cluster | AggreWell 400/800 microwells as a part of differentiation protocol | Human pluripotent stem cell | Improvement of stem-cell derived beta-cell establishment protocol for diverse applications such as small molecule screening | [306] |
Cluster Spheroid | Hanging drop | Dissociated rat islet and human bone marrow MSC | Capacity of MSCs to benefit in islet transplantation outcome by angiogenesis and anti-apoptosis | [307] |
Cluster Spheroid | Hanging drop | Dissociated rat islet and curcumin-loaded PLGA microspheres | Ability of beta-cell clusters to overcome hypoxia-induced death of transplantation through curcumin | [308] |
Vascularized islet | Low cell-adhesion 96-well plate with U-bottomed conical wells | Islet, HUVEC and human MSC | Development of vascularized islet organoid transplants to improve therapeutic efficacy | [309] |
Islet-like structure | During culture medium dependent differentiation (incubation with protamine chloride) | Human liver stem-like cell | Endocrine differentiation into islet-like structures and beta-cell replacement potential in STZ-induced diabetic mouse | [310] |
SC-islet | As a part of culture medium dependent differentiation (6-well AggreWell 400 plates followed by ultra-low attachment plates) | Human H1 | Detailed characterization from cytoarchitecture to insulin secretory machinery | [311] |
Stem-cell derived islet | AggreWell 400 plates and vertical-wheel bioreactors as a part of differentiation protocol | hiPSC | Generation and economical optimization of islet-like cluster with bioreactor included system and, characterization as well as analysis of effective islet transplantation mass | [312] |
Islet microtissue | 96-well hanging drop system | Dissociated human islet | As a model to determine the protective capacity of liraglutide on GSIS, cytokine secretion and T cell infiltration in islet microtissue-PBMC co-cultures | [313] |